Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 29 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact29 DOIs

Add abstracts to 18 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact18 DOIs

Deposit reference lists for 16 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact16 DOIs

DOIs for this ISSN

Showing the top 5 of 132 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Emerging roles and opportunities for rare disease patient ad… (10.1177/26330040231164425)	ORCID	38.29	33
2	Therapeutic and diagnostic advances in Stickler syndrome (10.1177/2633004020978661)	ORCID	31.38	17
3	A Systematic Review investigating the Effectiveness of Exerc… (10.1177/26330040221076497)	ORCID	26.98	11
4	Clinical evidence of interventions assessed in Friedreich at… (10.1177/26330040221139872)	ORCID	25.00	9
5	Developing a pathway to clinical trials for… (10.1177/26330040241245725)	ORCID	22.58	7
6	Utilizing telehealth to create a clinical model of care for… (10.1177/26330040211038564)	ORCID	19.45	5
7	Primary ovarian malignant mixed Müllerian tumor: a rare case… (10.1177/26330040221107389)	ORCID	19.45	5
8	Novel therapeutics in nystagmus: what has the genetics taugh… (10.1177/2633004021998714)	ORCID	17.47	4
9	Left-sided valvular heart disease and retinopathy in a 38-ye… (10.1177/26330040221145945)	ORCID	15.05	3
10	Understanding the perspective of patients with pulmonary art… (10.1177/2633004020986166)	Abstract	7.53	1
11	Successful combined umbilical cord blood and bone marrow tra… (10.1177/26330040231154283)	ORCID	7.53	1
12	The pharmacological treatment of granulomatosis with polyang… (10.1177/26330040231213888)	ORCID	7.53	1
13	An integrated action plan to fund and support drug developme… (10.1177/26330040241234932)	ORCID	7.53	1
14	Understanding patient, caregiver, and healthcare provider pe… (10.1177/26330040241252448)	ORCID	7.53	1
15	The emerging need to manage patient expectations of haemophi… (10.1177/26330040251330317)	Abstract	7.53	1
16	Introducing Therapeutic Advances in Rare Disease (10.1177/2633004020902860)	Abstract References ORCID	0.00	0
17	Congenital cataract: a guide to genetic and clinical managem… (10.1177/2633004020938061)		0.00	35
18	Role of red free imaging, retinal reflectance and fundus aut… (10.1177/2633004020958013)		0.00	0
19	A review of the treatment landscape in paroxysmal nocturnal… (10.1177/2633004020959349)		0.00	12
20	Conservative management of a fourth ventricular epidermoid i… (10.1177/2633004020969702)		0.00	1
21	Keratoconus: cross-linking the window of the eye (10.1177/26330040211003573)		0.00	5
22	Wiskott–Aldrich syndrome with normal platelet volume in a lo… (10.1177/26330040211009905)		0.00	3
23	A challenging start but a bright future (10.1177/26330040211010660)	Abstract References ORCID	0.00	0
24	IMPACT study: measuring the impact of caregiving on families… (10.1177/26330040211020764)		0.00	4
25	They’ve been BITTEN: reports of institutional and provider b… (10.1177/26330040211022033)		0.00	22
26	Enzyme replacement therapy in lysosomal acid lipase deficien… (10.1177/26330040211026928)		0.00	5
27	New avenues for therapy in mitochondrial optic neuropathies (10.1177/26330040211029037)		0.00	6
28	Wolfram syndrome: new pathophysiological insights and therap… (10.1177/26330040211039518)		0.00	13
29	Improving patient informed consent for haemophilia gene ther… (10.1177/26330040211047244)		0.00	11
30	Marfan syndrome and the eye clinic: from diagnosis to manage… (10.1177/26330040211055738)		0.00	6
31	Etranacogene dezaparvovec for hemophilia B gene therapy (10.1177/26330040211058896)		0.00	11
32	Beyond pigmentation: signs of liver protection during afamel… (10.1177/26330040211065453)		0.00	5
33	Therapeutic angiogenesis in Buerger’s disease: reviewing the… (10.1177/26330040211070295)		0.00	12
34	Pharmacology update: pamidronate for hypertrophic pulmonary… (10.1177/26330040211070298)		0.00	1
35	Animal and cellular models of microphthalmia (10.1177/2633004021997447)		0.00	5
36	What are the benefits of the anti-FGF23 antibody burosumab o… (10.1177/26330040221074702)		0.00	11
37	Telehealth for patients with rare epilepsies (10.1177/26330040221076861)		0.00	2
38	Impact of the Covid-19 epidemic on a US sample of patients w… (10.1177/26330040221082673)		0.00	4
39	Mannose treatment improves immune deficiency in mannose phos… (10.1177/26330040221091283)		0.00	3
40	Quality of life in Barth syndrome (10.1177/26330040221093743)		0.00	1
41	Future of genetic therapies for rare genetic diseases: what… (10.1177/26330040221100840)		0.00	17
42	Congenital disorder of glycosylation – one size does not fit… (10.1177/26330040221118099)		0.00	0
43	End-stage crystalline maculopathy with retinal atrophy in Sj… (10.1177/26330040221122496)		0.00	2
44	‘Granulomatosis with polyangiitis after Pfizer vaccination’:… (10.1177/26330040221130084)		0.00	8
45	Building cross-border collaborations to increase diversity a… (10.1177/26330040221133124)		0.00	3
46	Racial differences in the dermatological manifestations of t… (10.1177/26330040221140125)		0.00	1
47	Novel insights into the phenotype and long-term D-gal treatm… (10.1177/26330040221150269)		0.00	6
48	Papilledema and retinopathy lead to diagnosis of IgA nephrop… (10.1177/26330040231152957)		0.00	2
49	A novel case of homozygous PAX1 mutation associated with hyp… (10.1177/26330040231158776)		0.00	1
50	Bulbar conjunctival plexiform schwannoma in a 5-year-old pat… (10.1177/26330040231178321)		0.00	0